Literature DB >> 11029406

Cyclin A downregulation and p21(cip1) upregulation correlate with GATA-6-induced growth arrest in glomerular mesangial cells.

D Nagata1, E Suzuki, H Nishimatsu, M Yoshizumi, T Mano, K Walsh, M Sata, M Kakoki, A Goto, M Omata, Y Hirata.   

Abstract

The GATA-6 transcription factor is reported to be expressed in vascular myocytes. Because glomerular mesangial cells (GMCs) and vascular myocytes have similar properties, we examined whether GATA-6 was expressed in cultured GMCs and whether overexpression of GATA-6 induced cell cycle arrest in GMCs, using a recombinant adenovirus that expresses GATA-6 (Ad GATA-6). GATA-6 expression in GMCs was downregulated when quiescent GMCs were stimulated by serum to reenter the cell cycle. [(3)H]thymidine uptake was inhibited in GMCs infected with Ad GATA-6 in a dose- and time-dependent manner. The expression of cyclin A protein was decreased and that of the cyclin-dependent kinase inhibitor p21(cip1) was increased in GMCs infected with Ad GATA-6. Although the expression of p21(cip1) transcripts did not change remarkably, p21(cip1) protein was stabilized in GMCs infected with Ad GATA-6, suggesting a post-transcriptional regulation of p21(cip1) expression. Northern blot analysis showed that expression of the cyclin A transcript was decreased in Ad GATA-6-infected cells, whereas this decrease of cyclin A was not observed in GMCs derived from p21(cip1) null mice. Our results demonstrate that GATA-6 is endogenously expressed in GMCs and that overexpression of GATA-6 can induce cell cycle arrest. Our results also show that GATA-6-induced cell cycle arrest is associated with inhibition of cyclin A expression and p21(cip1) upregulation. Finally, our results indicate that the GATA-6-induced suppression of cyclin A expression depends on the presence of p21(cip1).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11029406     DOI: 10.1161/01.res.87.8.699

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  6 in total

Review 1.  Role of the GATA family of transcription factors in endocrine development, function, and disease.

Authors:  Robert S Viger; Séverine Mazaud Guittot; Mikko Anttonen; David B Wilson; Markku Heikinheimo
Journal:  Mol Endocrinol       Date:  2008-01-03

2.  Phosphorylation of GATA-6 is required for vascular smooth muscle cell differentiation after mTORC1 inhibition.

Authors:  Yi Xie; Yu Jin; Bethany L Merenick; Min Ding; Kristina M Fetalvero; Robert J Wagner; Alice Mai; Scott Gleim; David F Tucker; Morris J Birnbaum; Bryan A Ballif; Amelia K Luciano; William C Sessa; Eva M Rzucidlo; Richard J Powell; Lin Hou; Hongyu Zhao; John Hwa; Jun Yu; Kathleen A Martin
Journal:  Sci Signal       Date:  2015-05-12       Impact factor: 8.192

3.  GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model.

Authors:  Deepak Kamnasaran; Baoping Qian; Cynthia Hawkins; William L Stanford; Abhijit Guha
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-26       Impact factor: 11.205

4.  GATA4 reduction enhances 3',5'-cyclic adenosine 5'-monophosphate-stimulated steroidogenic acute regulatory protein messenger ribonucleic acid and progesterone production in luteinized porcine granulosa cells.

Authors:  Yvonne Y Hui; Holly A Lavoie
Journal:  Endocrinology       Date:  2008-07-24       Impact factor: 4.736

5.  Transcription factors GATA-4 and GATA-6 in normal and neoplastic human gastrointestinal mucosa.

Authors:  Hanna Haveri; Mia Westerholm-Ormio; Katri Lindfors; Markku Mäki; Erkki Savilahti; Leif C Andersson; Markku Heikinheimo
Journal:  BMC Gastroenterol       Date:  2008-04-11       Impact factor: 3.067

6.  Familial GATA6 mutation causing variably expressed diabetes mellitus and cardiac and renal abnormalities.

Authors:  Yang Timothy Du; Lynette Moore; Nicola K Poplawski; Sunita M C De Sousa
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2019-05-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.